Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A Randomized Phase III Trial of Thalidomide and...
Conference

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

Authors

Stewart K; Trudel S; Bahlis NJ; White DJ; Sabry W; Belch A; Reiman T; Roy J; Shustik C; Kovacs MJ

Volume

116

Pagination

pp. 23-23

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 19, 2010

Name of conference

52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

FL, Orlando

Conference start date

December 4, 2010

Conference end date

December 7, 2010

Conference proceedings

BLOOD

Issue

21

ISSN

0006-4971